Related Experiment Video
Updated: Jul 9, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.6K
A deep learning-based ADRPPA algorithm for the prediction of diabetic retinopathy progression.
Victoria Y Wang1, Men-Tzung Lo2, Ta-Ching Chen3,4
1Department of Ophthalmology, Keck School of Medicine, USC Roski Eye Institute, University of Southern California, Los Angeles, CA, USA.
Scientific Reports
|December 31, 2024
Summary
Artificial intelligence (AI) models predict diabetic retinopathy (DR) progression using longitudinal retinal images. This AI-driven Diabetic Retinopathy Progression Prediction Algorithm (ADRPPA) identifies high-risk patients for timely treatment.
Area of Science:
- Ophthalmology
- Artificial Intelligence
- Medical Imaging
Background:
- Diabetic retinopathy (DR) monitoring often relies on human experts.
- Current AI models offer diagnoses but lack predictive insights for DR prognosis and treatment.
- Longitudinal retinal imaging data holds potential for predicting DR progression.
Purpose of the Study:
- To develop and validate an AI-driven algorithm for predicting DR progression using longitudinal retinal imaging data.
- To assess the efficacy of deep learning models in forecasting the transition from nonreferable DR (NRDR) to referable DR (RDR).
Main Methods:
- Retrospective analysis of paired retinal fundus images from the EyePACS dataset (≥1-year intervals).
- Training a ResNeXt neural network for DR severity grading and a Mask R-CNN for microaneurysm quantification.
- Utilizing DR and microaneurysm scores to predict NRDR-to-RDR progression.
Main Results:
- ResNeXt models achieved high performance in diagnosing RDR (AUCs ranging from 0.963 to 0.971).
- Mask R-CNN demonstrated effective microaneurysm detection (recall: 0.786, precision: 0.615, F1-score: 0.690).
- The combined ResNeXt (768-pixel) and Mask R-CNN (1600-pixel) model predicted NRDR-to-RDR progression with an F1-score of 0.422.
Conclusions:
- Deep learning models trained on longitudinal data can effectively predict DR progression.
- AI-generated DR and microaneurysm scores aid in identifying patients at high risk for NRDR.
- This facilitates early intervention and timely treatment for diabetic retinopathy.

